Author

Cheol-Young Park

Institutions: Kangbuk Samsung Hospital, Sungkyunkwan University

Observed institutions: Kangbuk Samsung Hospital, Sungkyunkwan University

ORCID: 0000-0002-9415-9965

Observed ORCID: 0000-0002-9415-9965

OpenAlex ID: A5134501124

Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension

2026 · Jun Sung Moon, Kyung-Ah Han, et al. · Diabetes Research and Clinical Practice · 1

Hypertriglyceridemia in adults with diabetes mellitus in Korea: Sex, age, and lifestyle determinants

2026 · Kye-Yeung Park, Sangmo Hong, et al. · Journal of clinical lipidology

Works count: 2

Citation count: 1

H-index: 1

I10-index: